Clear Street raised the firm’s price target on Krystal Biotech (KRYS) to $217 from $212 and keeps a Buy rating on the shares after Krystal ...
Investor's Business Daily on MSN
Stocks To Watch: Krystal Biotech Sees RS Rating Rise To 86
The Relative Strength (RS) Rating for Krystal Biotech KRYS entered a new percentile Tuesday, with a rise from 80 to 86. IBD's ...
Krystal Biotech (NASDAQ:KRYS – Free Report) had its price objective trimmed by Chardan Capital from $219.00 to $216.00 in a research note issued to investors on Friday,Benzinga reports. The firm ...
Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback